Cabazitaxel-loaded anti-egfr immunoliposomes: targeted therapeutic strategy for prostate cancer

Os autores externos submeteram sua publicação para apresentação de trabalho no evento 'International Symposium on Immunobiologicals', que foi coordenado e organizado pelo Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), da Fundação Oswaldo Cruz.

Authors

Josimar O. Eloy (ORCID: https://orcid.org/0000-0003-3219-9969)
Raquel Petrilli (ORCID: https://orcid.org/0000-0003-2305-8566)
Ana Paula Prata (ORCID: https://orcid.org/0000-0001-7552-9716)

Publication Details

Published: 2025-01-01
DOI: https://doi.org/10.35259/isi.2025_70093
Primary Topic: Nanoparticle-Based Drug Delivery
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Cabazitaxel-loaded anti-egfr immunoliposomes: targeted therapeutic strategy for prostate cancer

Josimar O. Eloy, Raquel Petrilli, Ana Paula Prata

Jan 1, 2025

Nanoparticle-Based Drug Delivery

article

Cabazitaxel-loaded anti-egfr immunoliposomes: targeted therapeutic strategy for prostate cancer

Josimar O. Eloy, Raquel Petrilli, Ana Paula Prata

January 1, 2025article en

Abstract

Good health and well-being

Openalex Percentile: Top 94%

Nanoparticle-Based Drug Delivery

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Cabazitaxel-loaded anti-egfr immunoliposomes: targeted therapeutic strategy for prostate cancer — Josimar O. Eloy, Raquel Petrilli, et al. · (2025) | TGRS Research Map | TGRS